Aptose Biosciences
APTO
#10564
Rank
โ‚น0.40 B
Marketcap
โ‚น159.35
Share price
0.00%
Change (1 day)
-37.57%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -โ‚น1.77 Billion

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.36 Billion, an increase over its 2023 earnings that were of -โ‚น4.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น1.77 Billion-25.05%
2024 -โ‚น2.36 Billion-51.82%
2023 -โ‚น4.88 Billion22.9%
2022 -โ‚น3.97 Billion-34.91%
2021 -โ‚น6.1 Billion17.36%
2020 -โ‚น5.2 Billion107.65%
2019 -โ‚น2.51 Billion-7.73%
2018 -โ‚น2.72 Billion160.68%
2017 -โ‚น1.05 Billion-20.27%
2016 -โ‚น1.31 Billion28.71%
2015 -โ‚น1.02 Billion
2013 -โ‚น0.58 Billion
2010 -โ‚น0.49 Billion-8.31%
2009 -โ‚น0.54 Billion
2006 -โ‚น0.99 Billion-156.93%
2005 โ‚น1.73 B-185.16%
2004 -โ‚น2.05 Billion458.58%
2003 -โ‚น0.37 Billion-63.66%
2002 -โ‚น1.01 Billion-8.04%
2001 -โ‚น1.1 Billion16.73%
2000 -โ‚น0.94 Billion294.99%
1999 -โ‚น0.24 Billion-6.51%
1998 -โ‚น0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-โ‚น5.86 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-โ‚น6.3 Billion 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚น3.18 Billion 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA